Michael B. Aronson

Managing Director

Brett Topche

Managing Director

Past deals in Pennsylvania

Colugo

Series A in 2021
Provider of kids products designed for the new generation of parents. The company specializes in building a stroller that is compact, lightweight, folds effortlessly, stores discreetly and handles everything from steep hills to tight corners to crowded sidewalks, enabling parents to take their children easily everywhere and help them feel confident on their journey of parenthood.

Strella Biotechnology

Seed Round in 2020
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

MD Ally

Pre Seed Round in 2020
MD Ally, Inc. is a telemedicine platform founded in 2020 and based in Philadelphia, Pennsylvania. It offers a triage solution designed to enhance emergency medical services (EMS) by addressing non-emergency care needs. The platform enables EMS providers to triage callers with non-life-threatening issues to appropriate virtual medical and behavioral healthcare professionals, as well as facilitating in-network follow-up care, alternate transportation, and access to social services. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to improve patient-centered care options, ultimately enhancing clinical outcomes and reducing response and offload times for first responders. The service is provided at no cost to public safety entities, promoting collaboration between EMS and emergency room practitioners to optimize the use of emergency resources.

NeuroFlow

Series A in 2019
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.

Exyn

Series A in 2019
Exyn Technologies, Inc. is a Philadelphia-based company specializing in autonomous aerial robotics, having emerged from the GRASP Laboratory at the University of Pennsylvania. Founded in 2014, the company has developed exynAI, a modular software system that enables pilot-less flights for drones in complex commercial settings. This technology leverages multiple redundant sensors and advanced mapping techniques to facilitate obstacle avoidance and autonomous flight planning, allowing for applications such as underground inspections, inventory management, and construction documentation. Exyn's drones operate without human control or GPS, making them particularly suited for navigating challenging environments and automating hazardous tasks.

NeuroFlow

Venture Round in 2018
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.